发明名称 Systems and methods for determining insulin therapy for a patient
摘要 <p>In example methods and systems described, insulin therapy for a patient can be determined. At least one of a short-acting subcutaneous insulin dosage recommendation, a correction subcutaneous insulin dosage recommendation, an intravenous insulin dosage recommendation, a recommended amount of carbohydrates to be administered to the patient, or combinations thereof, can be determined. In addition, information indicating a confirmation of a nutrition intake for the patient, and a long-acting insulin-on-board for the patient can be received, and based on this information, a required long-acting subcutaneous or intravenous insulin dosage for the patient can be determined. The short-acting subcutaneous or intravenous insulin dosage recommendation can be adjusted based, at least in part, on a difference between the long-acting insulin-on-board and the required long-acting subcutaneous or intravenous insulin dosage.</p>
申请公布号 AU2012358357(A1) 申请公布日期 2014.07.17
申请号 AU20120358357 申请日期 2012.12.21
申请人 MONARCH MEDICAL TECHNOLOGIES, LLC 发明人 RUCHTI, TIMOTHY L.;BURGESS, WILLIAM PATRICK;DUMAS LLL, JOHN;LISIECKI, RONALD;MARTIN, CAROL DIAN;SANTANA, LAURA;THORNLEY, JOHN HARRISON;WATT, JOANNE MARIE
分类号 G06Q50/22 主分类号 G06Q50/22
代理机构 代理人
主权项
地址